CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
EU-OPENSCREEN aims to enhance early drug discovery by providing high-throughput screening and medicinal chemistry services. The project will integrate advanced technologies like artificial intelligence and new cell models to improve research outcomes and support a diverse user community in academia and industry.
EU-OPENSCREEN (EU-OS), the distributed European Research Infrastructure for Chemical Biology and early drug discovery, provides world-class services in high-throughput compound screening and medicinal chemistry to users from academia and industry.
As one of the largest open-access initiative globally, EU-OPENSCREEN plays an increasingly important role in facilitating early stage drug discovery in Europe.
It recently integrated fragment-based drug discovery and chemoproteomics as two new services…
EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM (EU-OPENSCREEN ERIC)
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Berlin
Type: Research institute
Activity type: Research Organisations
SME: No
UMG INSTITUTE OF MOLECULAR GENETICS ACA SCIEN CZECH REPU
Czechia, Praha 4
Type: Research institute
Activity type: Research Organisations
SME: No
Czechia, Olomouc
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Czechia, Brno
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
